BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 31126020)

  • 1. Establishment of Highly Transplantable Cholangiocarcinoma Cell Lines from a Patient-Derived Xenograft Mouse Model.
    Vaeteewoottacharn K; Pairojkul C; Kariya R; Muisuk K; Imtawil K; Chamgramol Y; Bhudhisawasdi V; Khuntikeo N; Pugkhem A; Saeseow OT; Silsirivanit A; Wongkham C; Wongkham S; Okada S
    Cells; 2019 May; 8(5):. PubMed ID: 31126020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actinidia arguta (Hardy Kiwi) Root Extract Exerts Anti-cancer Effects via Mcl-1-Mediated Apoptosis in Cholangiocarcinoma.
    Zhao X; Wen F; Wang W; Lu Z; Guo Q
    Nutr Cancer; 2019; 71(2):246-256. PubMed ID: 30633583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression.
    Erice O; Labiano I; Arbelaiz A; Santos-Laso A; Munoz-Garrido P; Jimenez-Agüero R; Olaizola P; Caro-Maldonado A; Martín-Martín N; Carracedo A; Lozano E; Marin JJ; O'Rourke CJ; Andersen JB; Llop J; Gómez-Vallejo V; Padro D; Martin A; Marzioni M; Adorini L; Trauner M; Bujanda L; Perugorria MJ; Banales JM
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1335-1344. PubMed ID: 28916388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and Characterization of Two Novel Cholangiocarcinoma Cell Lines.
    Zhang Y; Luo J; Dong X; Yang F; Zhang M; Zhao J; Wang Q; Zhou F; Sun J; Yang X
    Ann Surg Oncol; 2019 Nov; 26(12):4134-4147. PubMed ID: 31359275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ponatinib inhibits growth of patient-derived xenograft of cholangiocarcinoma expressing FGFR2-CCDC6 fusion protein in nude mice].
    Wu T; Jiang X; Xu B; Wang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Oct; 40(10):1448-1456. PubMed ID: 33118510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticholangiocarcinoma activity and toxicity of the Kaempferia galanga Linn. Rhizome ethanolic extract.
    Amuamuta A; Plengsuriyakarn T; Na-Bangchang K
    BMC Complement Altern Med; 2017 Apr; 17(1):213. PubMed ID: 28403856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer activity using positron emission tomography-computed tomography and pharmacokinetics of β-eudesmol in human cholangiocarcinoma xenografted nude mouse model.
    Plengsuriyakarn T; Karbwang J; Na-Bangchang K
    Clin Exp Pharmacol Physiol; 2015 Mar; 42(3):293-304. PubMed ID: 25545782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of membrane metalloendopeptidase inhibits substance P stimulation of cholangiocarcinoma growth.
    Meng F; DeMorrow S; Venter J; Frampton G; Han Y; Francis H; Standeford H; Avila S; McDaniel K; McMillin M; Afroze S; Guerrier M; Quezada M; Ray D; Kennedy L; Hargrove L; Glaser S; Alpini G
    Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(9):G759-68. PubMed ID: 24603459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of Metastatic Cholangiocarcinoma Patient-Derived Xenograft Models.
    Yáñez-Bartolomé M; Serra-Camprubí Q; Arenas EJ; Escorihuela M; Castet F; Fabregat-Franco C; Querol J; Arribas J; Peiró S; Macarulla T; Tian TV
    Methods Mol Biol; 2024; 2806():139-151. PubMed ID: 38676801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening.
    Broutier L; Mastrogiovanni G; Verstegen MM; Francies HE; Gavarró LM; Bradshaw CR; Allen GE; Arnes-Benito R; Sidorova O; Gaspersz MP; Georgakopoulos N; Koo BK; Dietmann S; Davies SE; Praseedom RK; Lieshout R; IJzermans JNM; Wigmore SJ; Saeb-Parsy K; Garnett MJ; van der Laan LJ; Huch M
    Nat Med; 2017 Dec; 23(12):1424-1435. PubMed ID: 29131160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor receptor inhibition induces loss of matrix MCL1 and necrosis in cholangiocarcinoma.
    Kabashima A; Hirsova P; Bronk SF; Hernandez MC; Truty MJ; Ilyas SI; Kaufmann SH; Gores GJ
    J Hepatol; 2018 Jun; 68(6):1228-1238. PubMed ID: 29408314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anticancer effects of Resina Draconis extract on cholangiocarcinoma.
    Wen F; Zhao X; Zhao Y; Lu Z; Guo Q
    Tumour Biol; 2016 Nov; 37(11):15203-15210. PubMed ID: 27683055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor Efficacy of the Herbal Recipe Benja Amarit against Highly Invasive Cholangiocarcinoma by Inducing Apoptosis both In Vitro and In Vivo.
    Yapasert R; Lertprasertsuk N; Subhawa S; Poofery J; Sripanidkulchai B; Banjerdpongchai R
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer activities against cholangiocarcinoma, toxicity and pharmacological activities of Thai medicinal plants in animal models.
    Plengsuriyakarn T; Viyanant V; Eursitthichai V; Picha P; Kupradinun P; Itharat A; Na-Bangchang K
    BMC Complement Altern Med; 2012 Mar; 12():23. PubMed ID: 22448640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and Preclinical Therapy of Patient-derived Hepatocellular Carcinoma Xenograft Model.
    Wu Y; Wang J; Zheng X; Chen Y; Huang M; Huang Q; Xiao W; Wei H; Tian Z; Sun R; Sun C
    Immunol Lett; 2020 Jul; 223():33-43. PubMed ID: 32335145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful Xenograft of Endoscopic Ultrasound-Guided Fine-Needle Aspiration Specimen from Human Extrahepatic Cholangiocarcinoma into an Immunodeficient Mouse.
    Jang SY; Bae HI; Lee IK; Park HK; Cho CM
    Gut Liver; 2015 Nov; 9(6):805-8. PubMed ID: 26087785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.
    Liu T; Yang H; Fan W; Tu J; Li TWH; Wang J; Shen H; Yang J; Xiong T; Steggerda J; Liu Z; Noureddin M; Maldonado SS; Annamalai A; Seki E; Mato JM; Lu SC
    Gastroenterology; 2018 Aug; 155(2):557-571.e14. PubMed ID: 29733835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of a chlorophyll derivative and investigation of its photodynamic activities against cholangiocarcinoma.
    Wu ZM; Wang L; Zhu W; Gao YH; Wu HM; Wang M; Hu TS; Yan YJ; Chen ZL
    Biomed Pharmacother; 2017 Aug; 92():285-292. PubMed ID: 28551549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma.
    Patt YZ; Hassan MM; Aguayo A; Nooka AK; Lozano RD; Curley SA; Vauthey JN; Ellis LM; Schnirer II; Wolff RA; Charnsangavej C; Brown TD
    Cancer; 2004 Aug; 101(3):578-86. PubMed ID: 15274071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase 3 overexpression in human cholangiocarcinoma and promotion of cell growth via apoptosis inhibition.
    Yin Y; Zhang M; Dorfman RG; Li Y; Zhao Z; Pan Y; Zhou Q; Huang S; Zhao S; Yao Y; Zou X
    Cell Death Dis; 2017 Jun; 8(6):e2856. PubMed ID: 28569784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.